Financials data is unavailable for this security.
View more
Year on year Somnomed Ltd had net income fall 53.04% from a loss of 8.00m to a larger loss of 12.24m despite a 9.64% increase in revenues from 83.62m to 91.68m. An increase in the selling, general and administrative costs as a percentage of sales from 60.84% to 62.91% was a component in the falling net income despite rising revenues.
Gross margin | 60.17% |
---|---|
Net profit margin | -13.35% |
Operating margin | -12.29% |
Return on assets | -18.51% |
---|---|
Return on equity | -36.31% |
Return on investment | -26.05% |
More ▼
Cash flow in AUDView more
In 2024, Somnomed Ltd increased its cash reserves by 35.32%, or 4.22m. Cash Flow from Financing totalled 16.68m or 18.19% of revenues. In addition the company used 6.33m for operations while cash used for investing totalled 5.34m.
Cash flow per share | -0.0536 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.3376 |
---|---|
Tangible book value per share | 0.1853 |
More ▼
Balance sheet in AUDView more
Current ratio | 1.76 |
---|---|
Quick ratio | 1.45 |
Total debt/total equity | 0.1493 |
---|---|
Total debt/total capital | 0.1299 |
More ▼